Company intelligence / Profile preview

Beijing Pharmaceutical Group

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing SL Pharmaceutical is a leading Chinese pharma/biotech company with over 200 patents and a diversified commercial portfolio focused on recombinant proteins, gene-engineered drugs, and biosimilars for oncology, hematologic, and liver diseases. Several products, such as recombinant human interleukins and growth factors, are approved and in widespread clinical use domestically, and the company is advancing new clinical candidates annually.[1][5][8][9]

Therapeutic areas: GastroenterologyHematologyDermatologyOncologyNeurology
Modalities: Biological productsBiosimilarSmall moleculeHormoneInterleukinGene engineering
Industry: Biotech

Partnerships

International pharmaceutical companies in Europe and North America (distribution and co-development partnerships as of 2023)

Beyond the preview

Go deeper on Beijing Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Pharmaceutical Group.

Explore the full profile